Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- Meeting of CDFS's Department on Drugs
September 26, 2005
- NEW PRODUCTS
September 26, 2005
- JMA's Involvement in Recommendation of Reps. of Hosp. Org. Necessary: Korosho
September 26, 2005
- MARKET SURVEY
September 26, 2005
- REGULATORY NEWS IN BRIEF
September 26, 2005
- GENERICS NEWS IN BRIEF
September 26, 2005
- JPLA LECTURE
September 26, 2005
- Innovative Drugs Should Be Valued More Highly: Mr Otsuji
September 26, 2005
- Taisho Toyama Aims at \120 Mil. Sales per MR ASAP: Mr Uehara of Taisho
September 26, 2005
- Mr Fujii, New President of QTJ, Introduced by Dr Gillings
September 26, 2005
- Alfresa HD, Meisyo to Merge in April 2006
September 26, 2005
- BUSINESS NEWS IN BRIEF
September 26, 2005
- Greater Disclosure Raises Public's Confidence in Company: Dr Breier of Eli Lilly
September 26, 2005
- JPMA to Revise Guidance on Supply of Control Drugs
September 26, 2005
- JPMA to Advocate Improvements in NDA Review, Clinical Trial Consultation Systems
September 26, 2005
- EDC Increases Work Speed, Cuts Costs: JPMA Seminar
September 26, 2005
- ABMJ Proposes Fund for Development of New Influenza Vaccines
September 19, 2005
- TOPICS 2 articles
September 19, 2005
- Association Calls on Gov't to Support Vaccine Business
September 19, 2005
- Orders for Flu Vaccine on aPar with Last Year's: Korosho
September 19, 2005
ページ
Japan is ramping up its push to spread regional formularies nationwide, a policy expected to standardize treatments, strengthen supply resilience,…
We had just gotten off a call with a client in Europe, and we’d received a bit of an earful. “Philip,” the client pressed, “what can this candidate bring to us? We know what he does, but what has he…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…